Saxagliptin beyond glycemic control: a comprehensive review

This review will provide insight into Saxagliptin, a potential neuroprotective rather than a well-established anti diabetic drug. Both glycemic and neuronal effects of Saxagliptin are mainly mediated through glucagon-like peptide-1 (GLP-1) and to a lesser extent dipeptidyl peptidase-4 (DPP-4) so,...

Descripció completa

Dades bibliogràfiques

Autors principals:	Maha M. Abdrabou, Enas Elmowafy, Haidy E. Michel, Samar S. Azab
Format:	Artigo
Idioma:	Inglês
Publicat:	Ain Shams University 2024-12-01
Col·lecció:	Archives of Pharmaceutical Sciences Ain Shams University
Matèries:	glp-1 dpp-4 parkinson's disease alzheimer's disease neuroprotection
Accés en línia:	https://aps.journals.ekb.eg/article_397110_858bc917a3c56cb285af727394d2b4c6.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!